Wegovy Side Effects in Females: What to Expect at Each Stage

Step 1: the first few weeks, what almost everyone notices

The Wegovy titration schedule starts at a low dose precisely because the body needs time to adapt to semaglutide's effects on gastric emptying and appetite signalling. For most women, that adaptation period shows up as nausea. It often arrives within an hour or two of injection and can be accompanied by reduced appetite, mild fatigue, or loose stools. The first instinct is to wonder whether something has gone wrong. It usually hasn't.

Keeping a light snack nearby before injecting, avoiding rich or fatty meals on injection day, and eating smaller portions all help. Many women find keeping the pen in the fridge door and injecting at the same point in their weekly routine makes it easier to spot patterns and plan around them. These are practical details our prescribers discuss with patients regularly, because the difference between dropping out and pushing through the first four weeks is often just knowing what to expect.

Other early effects include burping, indigestion, headache, and dizziness. Injection-site redness or mild discomfort at the abdomen, thigh or upper arm is normal and usually short-lived. None of these require stopping treatment, but they should be logged and mentioned at your next clinical review.

Step 2: dose increases and the pattern that repeats

Each time your dose steps up, the side-effect picture can briefly reset. Women who sailed through the first month sometimes find the move to 1.0 mg or 1.7 mg brings a fresh wave of nausea. This is not a sign the medicine has stopped agreeing with you; it is the same adjustment process playing out again at a higher level of receptor activity.

Clinical trial data from the STEP 1 study, published in the New England Journal of Medicine, showed that gastrointestinal events were most frequent during the escalation phase and generally resolved over time. Understanding this cycle ahead of each increase is one reason the consultation and ongoing clinical review matter, a prescriber can slow the titration if effects are consistently difficult to manage.

Constipation is more likely at higher doses, especially if fluid and fibre intake drops alongside a reduced appetite. It is worth being deliberate about both. Some women also find they experience no side effects on Wegovy, which can feel unexpected but is entirely possible. For further context on how women experience Wegovy's effects compared with men, the side effects in men page covers what differs and what doesn't.

Step 3: female-specific factors your prescriber needs to know about

Certain aspects of female physiology interact with Wegovy in ways that are worth flagging explicitly. Oral contraceptive pills are absorbed through the gut, and because semaglutide slows gastric emptying, there is a theoretical risk of reduced pill absorption, particularly relevant in the early weeks of treatment. NHS England advises discussing contraception with your doctor before starting; this is covered thoroughly on the NHS England weight-management injections page.

Women taking HRT in oral tablet form face a similar absorption question. Transdermal options such as patches or gels bypass that concern and may be preferable while on semaglutide, again, a prescriber's call rather than something to adjust independently.

Hair thinning is another experience that comes up more often in females than the clinical trial side-effect tables might suggest, and if you want to understand whether Wegovy can cause hair loss in females and what drives it, that page explains the evidence clearly. It typically reflects the physical stress of rapid weight change rather than a direct drug effect. If this is something you're concerned about, our guide on how to stop hair loss from Wegovy for females covers the mechanism and what helps. Our clinical team can also discuss whether any particular factor in your history changes the picture.

When to get medical help, symptoms that need urgent attention

Most Wegovy side effects are uncomfortable rather than dangerous, but there are specific signs that require prompt medical attention rather than watching and waiting. Seek help urgently if you experience severe stomach pain that does not ease and radiates toward your back, with or without vomiting. This pattern can indicate acute pancreatitis, which the MHRA highlighted as a known but infrequent serious risk in a Drug Safety Update issued in January 2026.

Other reasons to contact a doctor or call 111 include signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing), symptoms of significant dehydration from prolonged vomiting or diarrhoea, gallbladder pain (sharp pain under the right rib, especially after eating), or any new or worsening low mood or thoughts of self-harm. These are not reasons to stop the pen without speaking to someone first (stopping abruptly carries its own clinical considerations) but they are reasons not to wait for a scheduled review.

If you notice something you're unsure about, the right move is always to contact your prescriber. At nume, our aftercare team is available seven days a week, you can reach us via the contact page. For a broader look at the full side-effect profile beyond female-specific factors, the Wegovy side effects page goes into further detail.